257 related articles for article (PubMed ID: 18420583)
1. Insulin-like growth factor-I stimulates Shc-dependent phosphatidylinositol 3-kinase activation via Grb2-associated p85 in vascular smooth muscle cells.
Radhakrishnan Y; Maile LA; Ling Y; Graves LM; Clemmons DR
J Biol Chem; 2008 Jun; 283(24):16320-31. PubMed ID: 18420583
[TBL] [Abstract][Full Text] [Related]
2. Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells.
Ling Y; Maile LA; Lieskovska J; Badley-Clarke J; Clemmons DR
Mol Biol Cell; 2005 Jul; 16(7):3353-64. PubMed ID: 15888547
[TBL] [Abstract][Full Text] [Related]
3. p66shc negatively regulates insulin-like growth factor I signal transduction via inhibition of p52shc binding to Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 leading to impaired growth factor receptor-bound protein-2 membrane recruitment.
Xi G; Shen X; Clemmons DR
Mol Endocrinol; 2008 Sep; 22(9):2162-75. PubMed ID: 18606861
[TBL] [Abstract][Full Text] [Related]
4. Hyperglycemia-induced p66shc inhibits insulin-like growth factor I-dependent cell survival via impairment of Src kinase-mediated phosphoinositide-3 kinase/AKT activation in vascular smooth muscle cells.
Xi G; Shen X; Radhakrishnan Y; Maile L; Clemmons D
Endocrinology; 2010 Aug; 151(8):3611-23. PubMed ID: 20534722
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1 function in vascular smooth muscle cells.
Radhakrishnan Y; Busby WH; Shen X; Maile LA; Clemmons DR
J Biol Chem; 2010 May; 285(21):15682-95. PubMed ID: 20207740
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis.
Sasaoka T; Ishiki M; Wada T; Hori H; Hirai H; Haruta T; Ishihara H; Kobayashi M
Endocrinology; 2001 Dec; 142(12):5226-35. PubMed ID: 11713219
[TBL] [Abstract][Full Text] [Related]
7. The role of Src kinase in insulin-like growth factor-dependent mitogenic signaling in vascular smooth muscle cells.
Lieskovska J; Ling Y; Badley-Clarke J; Clemmons DR
J Biol Chem; 2006 Sep; 281(35):25041-53. PubMed ID: 16825188
[TBL] [Abstract][Full Text] [Related]
8. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling.
Kim B; Cheng HL; Margolis B; Feldman EL
J Biol Chem; 1998 Dec; 273(51):34543-50. PubMed ID: 9852124
[TBL] [Abstract][Full Text] [Related]
9. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
Besset V; Scott RP; Ibáñez CF
J Biol Chem; 2000 Dec; 275(50):39159-66. PubMed ID: 10995764
[TBL] [Abstract][Full Text] [Related]
10. p66shc inhibits insulin-like growth factor-I signaling via direct binding to Src through its polyproline and Src homology 2 domains, resulting in impairment of Src kinase activation.
Xi G; Shen X; Clemmons DR
J Biol Chem; 2010 Mar; 285(10):6937-51. PubMed ID: 20048152
[TBL] [Abstract][Full Text] [Related]
11. Recruitment of Pyk2 to SHPS-1 signaling complex is required for IGF-I-dependent mitogenic signaling in vascular smooth muscle cells.
Shen X; Xi G; Radhakrishnan Y; Clemmons DR
Cell Mol Life Sci; 2010 Nov; 67(22):3893-903. PubMed ID: 20521079
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
[TBL] [Abstract][Full Text] [Related]
13. PDK1 recruitment to the SHPS-1 signaling complex enhances insulin-like growth factor-i-stimulated AKT activation and vascular smooth muscle cell survival.
Shen X; Xi G; Radhakrishnan Y; Clemmons DR
J Biol Chem; 2010 Sep; 285(38):29416-24. PubMed ID: 20643654
[TBL] [Abstract][Full Text] [Related]
14. Recruitment of the tyrosine phosphatase Src homology 2 domain tyrosine phosphatase-2 to the p85 subunit of phosphatidylinositol-3 (PI-3) kinase is required for insulin-like growth factor-I-dependent PI-3 kinase activation in smooth muscle cells.
Kwon M; Ling Y; Maile LA; Badley-Clark J; Clemmons DR
Endocrinology; 2006 Mar; 147(3):1458-65. PubMed ID: 16306077
[TBL] [Abstract][Full Text] [Related]
15. Hyperglycemia alters the responsiveness of smooth muscle cells to insulin-like growth factor-I.
Maile LA; Capps BE; Ling Y; Xi G; Clemmons DR
Endocrinology; 2007 May; 148(5):2435-43. PubMed ID: 17255202
[TBL] [Abstract][Full Text] [Related]
16. CD16-mediated activation of phosphatidylinositol-3 kinase (PI-3K) in human NK cells involves tyrosine phosphorylation of Cbl and its association with Grb2, Shc, pp36 and p85 PI-3K subunit.
Cerboni C; Gismondi A; Palmieri G; Piccoli M; Frati L; Santoni A
Eur J Immunol; 1998 Mar; 28(3):1005-15. PubMed ID: 9541596
[TBL] [Abstract][Full Text] [Related]
17. Expression of the human beta3 integrin subunit in mouse smooth muscle cells enhances IGF-I-stimulated signaling and proliferation.
Xi G; Maile LA; Yoo SE; Clemmons DR
J Cell Physiol; 2008 Feb; 214(2):306-15. PubMed ID: 17607710
[TBL] [Abstract][Full Text] [Related]
18. The critical role of c-Src and the Shc/Grb2/ERK2 signaling pathway in angiotensin II-dependent VSMC proliferation.
Sayeski PP; Ali MS
Exp Cell Res; 2003 Jul; 287(2):339-49. PubMed ID: 12837289
[TBL] [Abstract][Full Text] [Related]
19. Src-family tyrosine kinases in activation of ERK-1 and p85/p110-phosphatidylinositol 3-kinase by G/CCKB receptors.
Daulhac L; Kowalski-Chauvel A; Pradayrol L; Vaysse N; Seva C
J Biol Chem; 1999 Jul; 274(29):20657-63. PubMed ID: 10400698
[TBL] [Abstract][Full Text] [Related]
20. Different pathways of postreceptor desensitization following chronic insulin treatment and in cells overexpressing constitutively active insulin receptors.
Inoue G; Cheatham B; Kahn CR
J Biol Chem; 1996 Nov; 271(45):28206-11. PubMed ID: 8910437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
